Correlation Between Boston Scientific and Novacyt SA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Boston Scientific and Novacyt SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Boston Scientific and Novacyt SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Boston Scientific Corp and Novacyt SA, you can compare the effects of market volatilities on Boston Scientific and Novacyt SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Boston Scientific with a short position of Novacyt SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Boston Scientific and Novacyt SA.

Diversification Opportunities for Boston Scientific and Novacyt SA

-0.82
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Boston and Novacyt is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Boston Scientific Corp and Novacyt SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novacyt SA and Boston Scientific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Boston Scientific Corp are associated (or correlated) with Novacyt SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novacyt SA has no effect on the direction of Boston Scientific i.e., Boston Scientific and Novacyt SA go up and down completely randomly.

Pair Corralation between Boston Scientific and Novacyt SA

Considering the 90-day investment horizon Boston Scientific is expected to generate 1.31 times less return on investment than Novacyt SA. But when comparing it to its historical volatility, Boston Scientific Corp is 6.12 times less risky than Novacyt SA. It trades about 0.12 of its potential returns per unit of risk. Novacyt SA is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  82.00  in Novacyt SA on September 19, 2024 and sell it today you would lose (12.00) from holding Novacyt SA or give up 14.63% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Boston Scientific Corp  vs.  Novacyt SA

 Performance 
       Timeline  
Boston Scientific Corp 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Boston Scientific Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Boston Scientific is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Novacyt SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novacyt SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Boston Scientific and Novacyt SA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Boston Scientific and Novacyt SA

The main advantage of trading using opposite Boston Scientific and Novacyt SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Boston Scientific position performs unexpectedly, Novacyt SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novacyt SA will offset losses from the drop in Novacyt SA's long position.
The idea behind Boston Scientific Corp and Novacyt SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments